Back to News
Market Impact: 0.12
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
Source: gurufocus.com
Company FundamentalsMarket Technicals & FlowsInvestor Sentiment & Positioning
iRadimed (IRMD) shares are down 3.8% to $83.45, following a notable decline from a 52-week high of $107.90. The excerpt provides no company-specific catalyst, so the move appears to reflect price action/sentiment rather than new fundamentals.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.12
Ticker Sentiment
IRMD-0.12
More News
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- Indonesia Said to Meet Monday With MSCI Over Shock Index Threat
- Nifty Bank Heavyweights HDFC, ICICI in Focus After Weekend Earnings
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Asian stocks skid, Wall Street and bonds aided by oil slip
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AllMind Fixed Income Compass for October 2025: Navigating Policy Divergence and Political Risk
- AI Equity Research Tools for RIAs and Wealth Managers